Millennium Management Portfolio holdings
Millennium Management, founded in 1989 by Israel (Izzy) Englander and Ronald Shear and headquartered in New York City, is a global multi-strategy hedge fund managing over $71 billion in assets as of late 2024, employing a decentralized model with over 300 independent trading teams. Operating across equities, fixed income, commodities, currencies, and derivatives, the firm uses a mix of quantitative and fundamental strategies, providing its portfolio managers with capital, infrastructure, and autonomy to pursue diverse investment approaches while enforcing strict risk management. With more than 5,400 employees across offices in London, Hong Kong, Singapore, and beyond, Millennium has evolved from its initial $35 million seed capital—partly from the Belzberg family—into a titan of the hedge fund world, known for its ability to attract top talent and deliver consistent returns. Under Englander’s leadership as chairman and CEO, the firm remains a low-profile yet highly influential force in global finance.
Top Buys
| 1 |
iShares MSCI Emerging Markets ETF
EEM
|
+$530M |
| 2 |
ATVI
Activision Blizzard Inc.
ATVI
|
+$448M |
| 3 |
CERN
Cerner Corp
CERN
|
+$285M |
| 4 |
Exxon Mobil
XOM
|
+$252M |
| 5 |
Norfolk Southern
NSC
|
+$246M |
Top Sells
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.37B |
| 2 |
SPDR S&P 500 ETF Trust
SPY
|
+$1.34B |
| 3 |
Apple
AAPL
|
+$1B |
| 4 |
NVIDIA
NVDA
|
+$836M |
| 5 |
Tesla
TSLA
|
+$595M |
Sector Composition
| 1 | Technology | 16.62% |
| 2 | Financials | 15.26% |
| 3 | Healthcare | 14.17% |
| 4 | Industrials | 9.83% |
| 5 | Consumer Discretionary | 9.1% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
451
Neurocrine Biosciences
NBIX
$14B
| $46.9M | 0.02% |
500,127
-60,870
| -11% | -$5.71M |
|
452
Carlisle Companies
CSL
$16.5B
| $46.7M | 0.02% |
189,884
+65,832
| +53% | +$16.2M |
|
453
PVH
PVH
$3.9B
| $46.6M | 0.02% |
608,280
+598,100
| +5,875% | +$45.8M |
|
454
Enovis
ENOV
$1.77B
| $46.6M | 0.02% |
680,162
+382,599
| +129% | +$26.2M |
|
455
ATI
ATI
$10.5B
| $46.6M | 0.02% |
1,734,861
+182,369
| +12% | +$4.89M |
|
456
EPAM Systems
EPAM
$8.7B
| $46.5M | 0.02% |
156,808
+82,922
| +112% | +$24.6M |
|
457
Thomson Reuters
TRI
$77.5B
| $46.3M | 0.02% |
410,311
+318,239
| +346% | +$35.9M |
|
458
First Interstate BancSystem
FIBK
$3.4B
| $46.2M | 0.02% |
1,256,574
+675,999
| +116% | +$24.9M |
|
459
Zscaler
ZS
$44B
| $46.1M | 0.02% |
191,214
+119,616
| +167% | +$28.9M |
|
460
Steven Madden
SHOO
$2.2B
| $46M | 0.02% |
1,191,631
+95,405
| +9% | +$3.69M |
|
461
American Water Works
AWK
$27.1B
| $45.8M | 0.02% |
276,841
+195,577
| +241% | +$32.4M |
|
462
Booz Allen Hamilton
BAH
$12.5B
| $45.8M | 0.02% |
521,456
+359,559
| +222% | +$31.6M |
|
463
Novavax
NVAX
$1.29B
| $45.4M | 0.02% |
615,933
+609,312
| +9,203% | +$44.9M |
|
464
KBR
KBR
$6.32B
| $45.3M | 0.02% |
828,141
+269,240
| +48% | +$14.7M |
|
465
Wintrust Financial
WTFC
$9.25B
| $45.2M | 0.02% |
486,780
+62,786
| +15% | +$5.83M |
|
|
CPE
466
DELISTED
Callon Petroleum Company
CPE
| $45.1M | 0.02% |
+762,670
| New | +$45.1M |
|
467
Thermo Fisher Scientific
TMO
$181B
| $44.9M | 0.02% |
75,996
-38,700
| -34% | -$22.9M |
|
468
Simon Property Group
SPG
$58.2B
| $44.8M | 0.02% |
340,611
+189,238
| +125% | +$24.9M |
|
469
BioNTech
BNTX
$24.4B
| $44.6M | 0.02% |
261,436
+240,607
| +1,155% | +$41M |
|
|
ITCI
470
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $44.4M | 0.02% |
725,469
+92,312
| +15% | +$5.65M |
|
471
Charles Schwab
SCHW
$168B
| $44.4M | 0.02% |
526,353
+106,670
| +25% | +$8.99M |
|
472
Teladoc Health
TDOC
$1.34B
| $44.3M | 0.02% |
614,716
-176,446
| -22% | -$12.7M |
|
473
Dynatrace
DT
$14.2B
| $44M | 0.02% |
933,321
+206,182
| +28% | +$9.71M |
|
|
WWE
474
DELISTED
World Wrestling Entertainment
WWE
| $43.9M | 0.02% |
703,386
-197,168
| -22% | -$12.3M |
|
475
Glaukos
GKOS
$5.08B
| $43.8M | 0.02% |
757,833
+753,043
| +15,721% | +$43.5M |
|